BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 35597332)

  • 1. Efficacy of Potassium Supplementation in Hypokalemic Patients Receiving Peritoneal Dialysis: A Randomized Controlled Trial.
    Pichitporn W; Kanjanabuch T; Phannajit J; Puapatanakul P; Chuengsaman P; Parapiboon W; Treamtrakanpon W; Boonyakrai C; Matayart S; Katavetin P; Perl J; Praditpornilpa K; Eiam-Ong S; Tungsanga K; Johnson DW
    Am J Kidney Dis; 2022 Nov; 80(5):580-588.e1. PubMed ID: 35597332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potassium supplementation and long-term outcomes in chronic peritoneal dialysis patients with end-stage renal disease: a propensity score matching study.
    Zhang YF; Wang Q; Su YY; Yang S; Guo J; Luo J; Tang JM; Li HY
    Ren Fail; 2016 Nov; 38(10):1594-1600. PubMed ID: 27771983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of oral vitamin D supplementation on the prevention of peritoneal dialysis-related peritonitis: study protocol for a randomized controlled clinical trial.
    Zhang YH; Xu X; Pi HC; Yang ZK; Johnson DW; Dong J
    Trials; 2019 Nov; 20(1):657. PubMed ID: 31779675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperkalemia in chronic peritoneal dialysis patients.
    Elliott AB; Soliman KMM; Ullian ME
    Ren Fail; 2022 Dec; 44(1):217-223. PubMed ID: 35166182
    [No Abstract]   [Full Text] [Related]  

  • 5. Hypokalemia in Chinese peritoneal dialysis patients: prevalence and prognostic implication.
    Szeto CC; Chow KM; Kwan BC; Leung CB; Chung KY; Law MC; Li PK
    Am J Kidney Dis; 2005 Jul; 46(1):128-35. PubMed ID: 15983966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral vitamin D supplementation on the prevention of peritoneal dialysis-related peritonitis: A pilot randomised controlled trial.
    Zhang YH; Xu X; Pi HC; Yang ZK; Johnson DW; Dong J
    Perit Dial Int; 2024 Jan; 44(1):27-36. PubMed ID: 37408329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Racial and Ethnic Differences in Mortality Associated with Serum Potassium in Incident Peritoneal Dialysis Patients.
    Eriguchi R; Obi Y; Soohoo M; Rhee CM; Kovesdy CP; Kalantar-Zadeh K; Streja E
    Am J Nephrol; 2019; 50(5):361-369. PubMed ID: 31522173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypokalemia in peritoneal dialysis patients in Thailand: the pivotal role of low potassium intake.
    Virojanawat M; Puapatanakul P; Chuengsaman P; Boonyakrai C; Buranaosot S; Katavetin P; Praditpornsilpa K; Eiam-Ong S; Kanjanabuch T
    Int Urol Nephrol; 2021 Jul; 53(7):1463-1471. PubMed ID: 33428166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreasing IV Potassium in Pediatric Cardiac Intensive Care: Quality Improvement Project.
    Rhodes LA; Wall KM; Abernathy SL; Moellinger AB; Borasino S; Alten JA
    Pediatr Crit Care Med; 2016 Aug; 17(8):772-8. PubMed ID: 27362851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized, double-blind, placebo-controlled trial of spironolactone for hypokalemia in continuous ambulatory peritoneal dialysis patients.
    Yongsiri S; Thammakumpee J; Prongnamchai S; Tengpraettanakorn P; Chueansuwan R; Tangjaturonrasme S; Dinchuthai P
    Ther Apher Dial; 2015 Feb; 19(1):81-6. PubMed ID: 25196890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low Serum Potassium Levels and Clinical Outcomes in Peritoneal Dialysis-International Results from PDOPPS.
    Davies SJ; Zhao J; Morgenstern H; Zee J; Bieber B; Fuller DS; Sloand JA; Vychytil A; Kawanishi H; Johnson DW; Wang AY; Kanjananbuch T; Boongird S; Moraes TP; Badve SV; Pisoni RL; Perl J;
    Kidney Int Rep; 2021 Feb; 6(2):313-324. PubMed ID: 33615056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Patiromer on Serum Potassium Level in Patients With Hyperkalemia and Diabetic Kidney Disease: The AMETHYST-DN Randomized Clinical Trial.
    Bakris GL; Pitt B; Weir MR; Freeman MW; Mayo MR; Garza D; Stasiv Y; Zawadzki R; Berman L; Bushinsky DA;
    JAMA; 2015 Jul; 314(2):151-61. PubMed ID: 26172895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low Serum Potassium Levels Increase the Infectious-Caused Mortality in Peritoneal Dialysis Patients: A Propensity-Matched Score Study.
    Ribeiro SC; Figueiredo AE; Barretti P; Pecoits-Filho R; de Moraes TP;
    PLoS One; 2015; 10(6):e0127453. PubMed ID: 26091005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effectiveness of lactulose and sennosides for the prevention of peritoneal dialysis-related peritonitis: an open-label, randomized, active-controlled trial.
    Noppakun K; Narongchai T; Chaiwarith R; Wongsawad U; Vongsanim S; Ruengorn C; Nochaiwong S
    Ann Med; 2021 Dec; 53(1):365-374. PubMed ID: 33596746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of sodium zirconium cyclosilicate on potassium lowering for 28 days among outpatients with hyperkalemia: the HARMONIZE randomized clinical trial.
    Kosiborod M; Rasmussen HS; Lavin P; Qunibi WY; Spinowitz B; Packham D; Roger SD; Yang A; Lerma E; Singh B
    JAMA; 2014 Dec; 312(21):2223-33. PubMed ID: 25402495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-center, pragmatic, cluster-randomized, controlled trial of standardized peritoneal dialysis (PD) training versus usual care on PD-related infections (the TEACH-PD trial): trial protocol.
    Chow JSF; Boudville N; Cho Y; Palmer S; Pascoe EM; Hawley CM; Reidlinger DM; Hickey LE; Stastny R; Valks A; Vergara L; Movva R; Kiriwandeniya C; Candler H; Mihala G; Buisman B; Equinox KL; Figueiredo AE; Fuge T; Howard K; Howell M; Jaure A; Jose MD; Lee A; Miguel SS; Moodie JA; Nguyen TT; Pinlac G; Reynolds A; Saweirs WWM; Steiner-Lim GZ; TeWhare B; Tomlins M; Upjohn M; Voss D; Walker RC; Wilson J; Johnson DW
    Trials; 2023 Nov; 24(1):730. PubMed ID: 37964367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum potassium and cause-specific mortality in a large peritoneal dialysis cohort.
    Torlén K; Kalantar-Zadeh K; Molnar MZ; Vashistha T; Mehrotra R
    Clin J Am Soc Nephrol; 2012 Aug; 7(8):1272-84. PubMed ID: 22626960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraperitoneal Cefepime Monotherapy Versus Combination Therapy of Cefazolin Plus Ceftazidime for Empirical Treatment of CAPD-Associated Peritonitis: A Multicenter, Open-Label, Noninferiority, Randomized, Controlled Trial.
    Kitrungphaiboon T; Puapatanakul P; Chuengsaman P; Tiskajornsiri K; Halue G; Siribamrungwong M; Matayart S; Chongthanakorn K; Poonvivatchaikarn U; Boonyakrai C; Somboonsilp W; Katavetin P; Praditpornsilpa K; Eiam-Ong S; Johnson DW; Kanjanabuch T
    Am J Kidney Dis; 2019 Nov; 74(5):601-609. PubMed ID: 31331757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postdialysis Hypokalemia and All-Cause Mortality in Patients Undergoing Maintenance Hemodialysis.
    Ohnishi T; Kimachi M; Fukuma S; Akizawa T; Fukuhara S
    Clin J Am Soc Nephrol; 2019 Jun; 14(6):873-881. PubMed ID: 31048327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Utility of Potassium-Sparing Diuretics to Maintain Normal Serum Potassium in Peritoneal Dialysis Patients.
    Fülöp T; Zsom L; Rodríguez B; Afshan S; Davidson JV; Szarvas T; Dixit MP; Tapolyai MB; Rosivall L
    Perit Dial Int; 2017 1-2; 37(1):63-69. PubMed ID: 27282853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.